Cancer patients monitored for years after revolutionary cell therapy
NCT ID NCT07474051
Summary
This study follows patients who previously received AvenCell's CAR-T cell therapy in earlier clinical trials. Researchers want to understand the long-term safety and effectiveness of these cancer treatments over time. The study will track 178 patients with various blood cancers and prostate cancer to monitor for any delayed side effects and see how well the treatment continues to work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Universitätsmedizin Berlin
Berlin, Germany
-
Klinikum der Universität (LMU) Muenchen
Munich, Germany
-
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus
Dresden, Germany
-
Universitatsklinikum Ulm
Ulm, Germany
-
Universitätsklinikum Marburg
Marburg, Germany
Conditions
Explore the condition pages connected to this study.